...
首页> 外文期刊>PACE: Pacing and clinical electrophysiology >Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach?
【24h】

Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach?

机译:胎儿快速性心律失常的药物管理:我们准备好采取系统的,循证的方法了吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Fetal tachyarrhythmias are a life-threatening condition complicating a small proportion of normal pregnancies. Despite major advances in the (intrauterine) pharmacologic treatment of these arrhythmias over the last years major uncertainties remain. Among these are controversies in the choice of agents in relation to arrhythmia type, and timing and duration of treatment. Currently, no evidence-based approach to the management of fetal tachyarrhythmias is available. An international registry is proposed as an important step toward obtaining the necessary data to develop evidence-based management strategies.
机译:胎儿快速性心律失常是一种危及生命的疾病,使一小部分正常妊娠复杂化。尽管在最近几年中,这些心律失常的(宫内)药物治疗取得了重大进展,但仍存在很多不确定性。其中有关于心律失常类型,治疗时间和持续时间的药物选择方面的争议。目前,尚无基于证据的胎儿快速性心律失常管理方法。提议建立一个国际注册机构,作为获取必要数据以开发基于证据的管理策略的重要步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号